Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
BeOne Medicines
Eli Lilly and Company
Acerta Pharma BV
University Hospital, Lille
BeOne Medicines
Boryung Pharmaceutical Co., Ltd
Janssen Pharmaceutical K.K.
Xencor, Inc.
University College, London
BeiGene
BeiGene
X4 Pharmaceuticals
Calibr, a division of Scripps Research
University of Ulm
University of Rochester
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Mayo Clinic
University of Nebraska
Stanford University
Dartmouth-Hitchcock Medical Center
Agenus Inc.
French Innovative Leukemia Organisation
Canadian Cancer Trials Group
TG Therapeutics, Inc.
Eastern Cooperative Oncology Group
Abramson Cancer Center at Penn Medicine
Brown University
Karyopharm Therapeutics Inc
Dana-Farber Cancer Institute
Scripps Health
Columbia University
Dana-Farber Cancer Institute
TG Therapeutics, Inc.
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Dana-Farber Cancer Institute
Hackensack Meridian Health
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Northwestern University
Roswell Park Cancer Institute
Central Hospital, Nancy, France
Cancer Research UK
University College, London